Teladoc expects to bring in $2.03 billion in revenue in 2021, according to a preliminary filing with the U.S Securities and Exchange Commission, substantially above the high point of the telehealth giant’s previous guidance and almost doubling 2020’s topline, reports Healthcare Dive.
The vendor conducted an estimated 14.7 million visits in the 2021 fiscal year, CEO Jason Gorevic said Monday at J.P. Morgan’s annual investor conference. That’s again above the high end of its guidance, and up from 10.6 million visits in 2020.
Despite consistent revenue growth, the 20-year-old vendor has not yet turned a profit and is currently facing a skeptical market. Investors have been leery amid worries that demand for virtual care will drop off as COVID-19 cases do. Read more.
